source
- Roche signs $100 million upfront deal with Alector to advance Parkinson's researchRoche announced a partnership with biotech Alector focused on neuroscience and Parkinson's disease, providing an upfront cash payment of $100 million. The agreement aims to combine Roche's resourc…
- Biogen's litifilimab shows clear or almost clear skin in cutaneous lupus after one yearBiogen reported that its experimental antibody litifilimab produced clear or almost clear skin in patients with cutaneous lupus erythematosus after one year of treatment in a mid‑stage study. The r…